IQVIA Holdings | IQV - Des Atouts





Des Atouts Changement Date
Accenture USD 67.06B 2.37B 2025-12
Agilent USD 12.81B 86M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Cardinal Health USD 58.08B 2.86B 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cigna USD 157.92B 0 2025-12
Cognizant Technology Solutions USD 20.5B 192M 2026-03
Computer Programs Systems USD 402.53M 3.12M 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
CVS Health USD 253.54B 1.79B 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.43B 224M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Elevance Health USD 125.83B 4.33B 2026-03
Humana USD 55.28B 6.37B 2026-03
IBM USD 156.23B 4.35B 2026-03
Illumina USD 6.64B 467M 2025-12
Infosys INR 1.43T 169.96B 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Malin Corporation EUR 198.5M 70.1M 2024-12
McKesson USD 84.19B 30M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 395.08M 53.42M 2025-12
Publicis EUR 40.01B 3.93B 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Revvity USD 12.17B 29.46M 2025-12
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tilray USD 2.1B 15.95M 2025-09
UnitedHealth USD 312.64B 3.06B 2026-03
Veeva Systems USD 8.98B 882.19M 2025-12
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 5.08B 221.41M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09